BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Breast cancer

1. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305.